Navigation Links
GORE SMOOTHER Crucial Tool

ProductsGORE SMOOTHER Crucial Tool
Company W. L. Gore & Associates, Inc.
Item GORE SMOOTHER Crucial Tool
Features 
  • Trial prosthesis for assessment of the intercondylar notch in cruciate ligament replacement procedures.
  • Smooth the intercondylar notch and drill hole edges after chamfering
  • Approximate measurement for proper selection of graft.
  • Use to engage and place a graft.
  • Description The drilling and rasping necessary in cruciate ligament reconstruction procedures frequently leaves debris and roughness on the bone surface. This condition, if not rectified with a smoothing device, can damage the cruciate replacement. The GORE SMOOTHER Crucial Tool is designed to facilitate cruciate ligament reconstruction procedures. The tool functions as both a trial graft and a smoothing, measurement and graft introduction device. Its wire braids remove debris and smooth rough bone edges, while a pliable introducer allows for easy insertion and passage through bone tunnels. Packaged sterile, the GORE SMOOTHER Crucial Tool is intended for single use only.
    Info W. L. Gore & Associates, Inc.
    Customer Service: (800) 437-8181
    Web site: http://www.goremedical.com/

    Related medicine products :

    1. EpochXP Neurological Workstations
    2. The External Neurological Drainage System
    3. Biomek 2000 Laboratory Automation Workstation
    4. Biomek FX Laboratory Automation Workstation
    5. Finnigan ProteomeX™ Workstation
    6. Byrd Workstation Femoral Intravascular Retrieval Set
    7. Zyoptix Diagnostic Workstation
    8. The P45 Ultrasonic Workstation
    9. BEETHOVEN II Workstation Laboratory Information System
    10. Shandon Grosslab Junior Grossing Workstation
    11. Shandon Gross-Star Grossing Workstation
    For the quantitative in vitro determination of Total Protein in serum and plasma...
    The DBIL method used on the Dimension clinical chemistry system is an in vitro diagnostic test intended for the quantitative determination of direct (conjugated) bilirubin in serum and plasma....
    Latex agglutination slide test for the qualitative and semi-quantitative in vitro determination of Rheumatoid Factor in serum....
    For the quantitative in vitro determination of Carbon Dioxide in serum and plasma....
    Medicine Products:
    (Date:8/19/2017)... Texas (PRWEB) , ... August 19, 2017 , ... ... with contemporary illustrations of breastfeeding mothers. These illustrations show the diversity ... available in prints in a wide range of sizes. These illustrations are also ...
    (Date:8/19/2017)... ... ... “Congratulations! It's A Boy! God’s Gift: A Story of Love”: a children’s book ... A Boy! God’s Gift: A Story of Love” is the creation of published authors, ... by Christian Faith Publishing, Dale Anthony and Rachael Anthony’s new book is a perfect ...
    (Date:8/18/2017)... ... August 18, 2017 , ... ... (“Quick”), a highly specialized asset-light logistics provider of complex transport solutions for ... agreement to purchase Unitrans International Corporation, a division of Roadrunner Transportation Systems, ...
    (Date:8/18/2017)... ... August 18, 2017 , ... As an industry leader, ... webinar, they will present the line of epMotion automated liquid handling system. This ... can automate everyday pipetting tasks. , Ideal for scientists and lab technicians with ...
    (Date:8/18/2017)... TX (PRWEB) , ... August 18, 2017 , ... ... assistance and financial planning services to communities in east Texas, is launching a ... Brain Tumor Foundation. , Founded in 1991, the Pediatric Brain Tumor Foundation (PBTF) ...
    Breaking Medicine News(10 mins):
    (Date:8/15/2017)... 2017  Axium Pharmaceuticals Inc., the creator of the drug Truveta ... beginning stages of an IPO. The United States ... average cost of a prescription epilepsy drug being $450.00-$1200.00 for a one ... AXIUM PHARMACEUTICALS, INC ... Another staggering figure is the fact that Americans spent $42 billion ...
    (Date:8/14/2017)... and PETACH TIKVAH, Israel ... (NASDAQ: BCLI), a leading developer of adult stem cell ... second quarter ending June 30, 2017. ... of preparing for our pivotal Phase 3 trial to ... Lebovits , President and Chief Executive Officer of BrainStorm. ...
    (Date:8/8/2017)... 2017  BioLineRx Ltd. (NASDAQ/TASE: BLRX), a clinical-stage biopharmaceutical ... financial results for the second quarter ended June 30, ... quarter 2017 and to date: ... for the Company,s lead project, BL-8040: ... BL-8040 as novel stem cell mobilization treatment for autologous ...
    Breaking Medicine Technology: